§ BIOTECHNOLOGY
USD · Biotechnology

APLS

APELLIS PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · -0.24
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
0 increased/new, 1 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E233.5P/B8.59
EPS (TTM)0.12
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.13.5M0.0%+116%
Avoro Capital Advisors LLC12.2M4.8%n/a
Morgan Stanley10.0M0.0%n/a
State Street6.8M0.0%+48%
UBS Group AG6.2M0.0%+48%
VANGUARD PORTFOLIO MANAGEMENT LLC5.4Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for APLS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER97.2% · 0 holders
OTHER1.5% · 224 holders
DEALER / BANK0.6% · 30 holders
PASSIVE / INDEX0.3% · 9 holders
TACTICAL / MACRO0.1% · 8 holders
QUALITY / COMPOUNDER0.1% · 17 holders
SYSTEMATIC / QUANT0.1% · 12 holders
INCOME / DEFENSIVE0.1% · 25 holders
ACTIVIST0.0% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for APLS in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention APLS yet.